EX-10.1 2 dex101.htm DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020*[NOTE: CERTAIN PORTIONS OF THIS DOCUMENT HAVE BEEN MARKED TO INDICATE THAT CONFIDENTIAL INFORMATION HAS BEEN OMITTED. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THIS CONFIDENTIAL INFORMATION. THE CONFIDENTIAL PORTIONS HAVE BEEN PROVIDED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION]
DEVELOPMENT AND LICENSE AGREEMENT Contract No.: 43004344Development and License Agreement • May 10th, 2006 • Inspire Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMay 10th, 2006 Company IndustryWHEREAS, BII owns certain know-how, (in particular pre-formulation data, formulation data, pre-clinical data and clinical data), and patents relating to the active ingredient epinastine (as more fully hereinafter defined herein, the “Compound”);